The Role of Epidermal Growth Factor Receptor (EGFR) Targeting Drugs in the Treatment of Cancer

被引：0
作者：
Ciardiello, Fortunato [1 ]
Tortora, Giampaolo [2 ]
机构：
[1] Seconda Univ Napoli, Dipartimento Med Chirurg Internist Clin & Sperime, Naples, Italy
[2] Univ Napoli Federico II, Dipartimento Endocrinol & Oncol Mol & Clin, Naples, Italy
来源：
CURRENT CANCER THERAPY REVIEWS | 2007年 / 3卷 / 04期
关键词：
D O I：
10.2174/157339407782497040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：223 / 225
页数：3
相关论文
共 16 条
[1]  
Ciardiello F, 2001, CLIN CANCER RES, V7, P2958
[2]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[3]   Magic bullets [J].
Ezzell, C .
SCIENTIFIC AMERICAN, 2001, 285 (04) :34-41
[4]   Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival [J].
Grandis, JR ;
Melhem, MF ;
Gooding, WE ;
Day, R ;
Holst, VA ;
Wagener, MM ;
Drenning, SD ;
Tweardy, DJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (11) :824-832
[5]   Developing inhibitors of the epidermal growth factor receptor for cancer treatment [J].
Grünwald, V ;
Hidalgo, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :851-867
[6]   EGF mutant receptor vIII as a molecular target in cancer therapy [J].
Kuan, CT ;
Wikstrand, CJ ;
Bigner, DD .
ENDOCRINE-RELATED CANCER, 2001, 8 (02) :83-96
[7]   Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].
Lynch, TJ ;
Bell, DW ;
Sordella, R ;
Gurubhagavatula, S ;
Okimoto, RA ;
Brannigan, BW ;
Harris, PL ;
Haserlat, SM ;
Supko, JG ;
Haluska, FG ;
Louis, DN ;
Christiani, DC ;
Settleman, J ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139
[8]   Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer [J].
Mendelsohn, J ;
Baselga, J .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) :2787-2799
[9]  
MOSCATELLO DK, 1995, CANCER RES, V55, P5536
[10]   Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations [J].
Mukohara, T ;
Engelman, JA ;
Hanna, NH ;
Yeap, BY ;
Kobayashi, S ;
Lindeman, N ;
Halmos, B ;
Pearlberg, J ;
Tsuchihashi, Z ;
Cantley, LC ;
Tenen, DG ;
Johnson, BE ;
Jänne, PA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (16) :1185-1194
12